计算溶液所需的质量、体积或浓度。
VGX100 (anti-VEGFC) (Ab177881) - SEC
The purity of VGX100 (anti-VEGFC) (Ab177881) is more than 95% verified by HPLC.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab177881-100μg |
100μg |
现货 ![]() |
| |
| Ab177881-1mg |
1mg |
现货 ![]() |
| |
| Ab177881-5mg |
5mg |
现货 ![]() |
| |
| Ab177881-10mg |
10mg |
期货 ![]() |
|
| 产品名称 | VGX100 (anti-VEGFC) |
|---|---|
| 英文别名 | Flt4 ligand | Flt4-L | Vascular endothelial growth factor-related protein | VEGF-C | VRP |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | VEGFC |
| 种属反应性 | 人(Human) |
| 偶联 | Unconjugated |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | lambda |
| SDS-PAGE | 143.6 kDa |
| 纯化方法 | Protein A purified |
| 纯度 | >95% |
| 物理外观 | Liquid |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| 分子类型 | 抗体 |
VGX100 (anti-VEGFC) (Ab177881) - SEC
The purity of VGX100 (anti-VEGFC) (Ab177881) is more than 95% verified by HPLC.
VGX100 (anti-VEGFC) (Ab177881) - ELISA
Immobilized hVEGFC-his at 2.0 μg/mL can bind VGX100 (anti-VEGFC) (Ab177881) with the EC₅₀ of 4.16 ng/mL.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
| 分析证书 | 24-03-08 | Ab177881 | |
| 分析证书 | 24-03-08 | Ab177881 | |
| 分析证书 | 24-03-08 | Ab177881 |
| 1. Joukov, V V and 8 more authors.. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.. The EMBO journal, (1): [PMID:8612600] |
| 2. Joukov, V V and 8 more authors.. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.. The EMBO journal, (15): [PMID:8617204] |
| 3. Lee, J J and 5 more authors.. (1996) Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.. Proceedings of the National Academy of Sciences of the United States of America, (5): [PMID:8700872] |
| 4. Joukov, V V and 8 more authors.. (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C.. The EMBO journal, (1): [PMID:9233800] |
| 5. Fitz, L J LJ and 17 more authors.. (1997) Characterization of murine Flt4 ligand/VEGF-C.. Oncogene, (31): [PMID:9247316] |
| 6. Leppänen, Veli-Matti VM and 9 more authors.. (2010) Structural determinants of growth factor binding and specificity by VEGF receptor 2.. Proceedings of the National Academy of Sciences of the United States of America, (9): [PMID:20145116] |
| 7. Gordon, Kristiana K and 12 more authors.. (2013) Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.. Circulation research, (15): [PMID:23410910] |
| 8. Leppänen, Veli-Matti VM and 10 more authors.. (2013) Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation.. Proceedings of the National Academy of Sciences of the United States of America, (6): [PMID:23878260] |
| 9. Balboa-Beltran, Emilia E and 9 more authors.. (2014) A novel stop mutation in the vascular endothelial growth factor-C gene (VEGFC) results in Milroy-like disease.. Journal of medical genetics, [PMID:24744435] |